JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balbín, M.
Right arrow Articles by López-Otín, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balbín, M.
Right arrow Articles by López-Otín, C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 26, Issue of June 28, 1996 pp. 15782-15786
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Functional Analysis of a p21WAF1,CIP1,SDI1 Mutant (Arg94 right-arrow  Trp) Identified in a Human Breast Carcinoma
EVIDENCE THAT THE MUTATION IMPAIRS THE ABILITY OF p21 TO INHIBIT CYCLIN-DEPENDENT KINASES

(Received for publication, October 11, 1995, and in revised form, March 25, 1996)

Milagros Balbín , Gregory J. Hannon , Alberto M. Pendás , Adolfo A. Ferrando , Francisco Vizoso '' , Antonio Fueyo and Carlos López-Otín

From the Departamento de Biología Funcional, Facultad de Medicina, Universidad de Oviedo, 33006-Oviedo, Spain, the  Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, and the '' Servicio de Cirugía, Hospital de Jove, 33290 Gijón, Spain

Human p21 (also known as WAF1, CIP1, or SDI1) is a dual inhibitor of cyclin dependent kinases (CDKs) and the replication factor PCNA, which plays a role as a downstream mediator of the cell-cycle arrest induced by the tumor suppressor p53. To determine whether inactivation of downstream targets of p53 might contribute to cellular transformation, we have examined the integrity of the p21 gene in 36 invasive ductal breast carcinomas. Direct sequence analysis of the polymerase chain reaction-amplified p21 gene revealed a C to T transition in codon 94 that caused the substitution of a tryptophan for an arginine in a tumor specimen. This mutation was not detected in normal DNA extracted from the same patient nor in a polymerase chain reaction-restriction fragment length polymorphism of 50 unrelated individuals, indicating that it corresponds to a tumor-specific alteration. Functional analysis of the p21R94W protein produced in different eukaryotic and prokaryotic expression systems revealed that this mutation impaired the ability of p21 to inhibit CDKs. By contrast, the R94W mutant was unaltered in its ability to promote cyclin-CDK association as well as in its ability to bind proliferating cell nuclear antigen, thus leaving its putative functions as kinase activator or as inhibitor of replicative DNA synthesis intact. On the basis of these functional analysis, we propose that the Arg residue at position 94 is important for the CDK inhibitory role of p21.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
A. M. Abukhdeir, M. I. Vitolo, P. Argani, A. M. De Marzo, B. Karakas, H. Konishi, J. P. Gustin, J. Lauring, J. P. Garay, C. Pendleton, et al.
Tamoxifen-stimulated growth of breast cancer due to p21 loss
PNAS, January 8, 2008; 105(1): 288 - 293.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. F. Peterson, M. Yan, and D.-E. Zhang
The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO
Blood, May 15, 2007; 109(10): 4392 - 4398.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. Staalesen, B. Leirvaag, J. R. Lillehaug, and P. E. Lonning
Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer
Clin. Cancer Res., May 15, 2004; 10(10): 3438 - 3443.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Fan, A. D. Borowsky, and R. H. Weiss
An Antisense Oligodeoxynucleotide to p21Waf1/Cip1 Causes Apoptosis in Human Breast Cancer Cells
Mol. Cancer Ther., August 1, 2003; 2(8): 773 - 782.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L. A. Allan, T. Duhig, M. Read, and M. Fried
The p21WAF1/CIP1 Promoter Is Methylated in Rat-1 Cells: Stable Restoration of p53-Dependent p21WAF1/CIP1 Expression after Transfection of a Genomic Clone Containing the p21WAF1/CIP1 Gene
Mol. Cell. Biol., February 15, 2000; 20(4): 1291 - 1298.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
P. P. McKenzie, S. M. Guichard, D. S. Middlemas, R. A. Ashmun, M. K. Danks, and L. C. Harris
Wild-Type p53 Can Induce p21 and Apoptosis in Neuroblastoma Cells But the DNA Damage-induced G1 Checkpoint Function
Clin. Cancer Res., December 1, 1999; 5(12): 4199 - 4207.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Mitra, C. Y. Dai, K. Somasundaram, W. S. El-Deiry, K. Satyamoorthy, M. Herlyn, and G. H. Enders
Induction of p21WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16INK4a
Mol. Cell. Biol., May 1, 1999; 19(5): 3916 - 3928.
[Abstract] [Full Text] [PDF]

Home page
 Cell Growth Differ.Home page
J. M. Jones, X.-S. Cui, D. Medina, and L. A. Donehower
Heterozygosity of p21WAF1/CIP1 Enhances Tumor Cell Proliferation and Cyclin D1-associated Kinase Activity in a Murine Mammary Cancer Model
Cell Growth Differ., April 1, 1999; 10(4): 213 - 222.
[Abstract] [Full Text]

Home page
 Genes Dev.Home page
J. O. Funk, S. Waga, J. B. Harry, E. Espling, B. Stillman, and D. A. Galloway
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
Genes & Dev., August 15, 1997; 11(16): 2090 - 2100.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Derjuga, C. Richard, M. Crosato, P. S. Wright, L. Chalifour, J. Valdez, A. Barraso, H. A. Crissman, W. Nishioka, E. M. Bradbury, et al.
Expression of p21Waf1/Cip1 and Cyclin D1 Is Increased in Butyrate-resistant HeLa Cells
J. Biol. Chem., October 5, 2001; 276(41): 37815 - 37820.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.